Screen for MAOA mutations in target human groups

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 88, Issue 1, 1999, Pages 25-28

  Schuback, Deborah E ^a   Mulligan, Evan L ^a   Sims, Katherine B ^a   Tivol, Elizabeth A ^a   Greenberg, Benjamin D ^b   Chang, Shu Fen ^c   Yang, Show Lin ^c   Mau, Yi Chien ^c   Shen, Chen Yang ^c   Ho, Mei Shang ^c   Yang, Nan Hua ^d   Butler, Merlin G ^e   Fink, Stephen ^a   Schwartz, Charles E ^f   Berlin, F ^g   Breakefield, Xandra O ^a   Murphy, Dennis L ^b   Hsu, Yun Pung Paul ^h  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL TAINAN INSTITUTE OF NURSING   (Taiwan)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GREENWOOD GENETIC CENTER   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Biogenic amines; Genetics; Mental retardation; Monoamine oxidase; X linked disorders

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BIOGENIC AMINE;

ARTICLE; ENZYME DEFICIENCY; GENE DISRUPTION; GENE MUTATION; GENETIC SCREENING; HUMAN; MENTAL DEFICIENCY; PERSONALITY DISORDER; POPULATION RESEARCH; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SINGLE STRAND CONFORMATION POLYMORPHISM; STOP CODON; X CHROMOSOME LINKAGE;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENETIC SCREENING; HUMANS; MALE; MENTAL RETARDATION; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; MONOAMINE OXIDASE; PARAPHILIAS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA;

GENETTA;

EID: 0033525012     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990205)88:1<25::AID-AJMG4>3.0.CO;2-E     Document Type: Article

References (26)

1. Berlin FS, Hunt WP, Malin HM, Dyer A, Lahne GK, Dean S. 1991. A five-year plus follow-up survey of criminal recidivism within a treated cohort of 406 pedophiles, 111 exhibitionists and 109 sexual aggressive: Issues and outcome. Ame J Forensic Psychol 12:5-28.
2. Berry MD, Juorio AV, Paterson LA. 1994. The functional role of monoamine oxidases A and B in the mammalian central nervous system. Prog Neurobiol 42:375-391.
3. Bond PA, Cundall RL. 1977. Properties of monoamine oxidase (MAO) in human blood platelets, plasma, lymphocytes and granulocytes. Clin Chim Acta 80:317-326.
4. Brunner HG, Nelen MR, van Zundvoort P, Abeling NGGM, van Gennip AH, Wolters EC, Kulper MA. 1993a. X-linked borderline mental retardation with prominent behavioral disturbance: Phenotype, genetic localization and evidence for disturbed monoamine metabolism. Am J Hum Genet 52:1032-1039.
5. Brunner HG, Nelen M, Breakefield, XO, Ropers HH, van Oost BA. 1993b. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578-580.
6. Butler MG, Singh DN. 1993. Clinical and cytogenetic survey of institutionalized mentally retarded patients with emphasis on the fragile-X syndrome. J Intellect Disabil Res 37:131-142.
7. Butler MG, Pratesi R, Watson MS, Breg WR, Singh DN. 1993. Anthropometric and craniofacial patterns in the mentally retarded males with emphasis on the fragile X syndrome. Clin Genet 44:129-138.
8. Butler MG, Pratesi R, Vnencak-Jones CL. 1995. Molecular genetic analysis of mentally retarded males with features of the fragile-X syndrome. J Intellect Disabil Res 39:544-533.
9. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Muller U, Aguet M, Babinet C, Shih JC, De Maeyer E. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAO-A. Science 268:1763-1766.
10. Chen ZY, Hotamisligil G, Huang J-K, Wen L, Ezzeddine, DA, Muderrisoglu N, Powell JF. 1991. Structure of the human gene for monoamine oxidase type A. Nucleic Acids Res 19:4537-4541.
11. Chen ZY, Denney RM, Breakefield XO. 1995. Norrie disease and MAO genes - Nearest neighbors. Hum Mol Genet 4:1729-1737.
12. Costa MRC, Edelstein SB, Castiglione CM, Chao H, Breakefield XO. 1980. Properties of monoamine oxidase in control and Lesch-Nyhan fibroblasts. Biochem Genet 18:577-590.
13. Grimsby J, Chen K, Wang L-J, Lan NC, Shih JC. 1991. Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci USA 88:3637-3641.
14. Hotamisligil GS, Breakefield XO. 1991. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49:383-392.
15. Hotamisligil GS, Girmen AS, Fink SJ, Tivol E, Shalish C, Trofatter J, Baenziger J, Diamond S, Markham C, Sullivan J. 1994. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov Disord 9:305-310.
16. Lenders JWM, Elsenhofer G, Abeling NGGM, Berger W, Murphy DL, Konings CH, Bleeker-Wagemakers LM, Kopin IJ, Karoum F, van Gennip AH, Brunner HG. 1996. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J Clin Invest 97:1010-1019.
17. Murphy DL, Kalin NH. 1980. Biological and behavioral consequences of alterations in monoamine oxidase activity. Schizophr Bull 6:355-367.
18. Murphy DL, Wright C, Buchsbaum M, Costa J, Nichols A, Wyatt R. 1976. Platelet and plasma amine activities in 680 normals: Sex and age differences and stability over time. Biochem Med 16:254-265.
19. Murphy DL, Garrick NA, Cohen RM. 1983. Monoamine oxidase inhibitors and monoamine oxidase: biochemical and physiological aspects relevant to human psycho-pharmacology. In: Burrows GD, Norman TR, Davies B, editors. Antidepressants. Amsterdam: Elsevier, p 209-227.
20. Orita M, Suzuki Y, Sekyia T, Hayashi K. 1989. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879.
21. Pickar D, Cohen RM, Jimerson DC, Lake CR, Murphy DL. 1981. Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction. Psychopharmacology (Berlin) 74:8-12.
22. Scheinin M, Chang W-H, Kirk KL, Linnoila M. 1983. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid with high performance liquid chromatography using electrochemical detection. Anal Biochem 131:246-253.
23. Sims KB, de la Chapelle A, Norio R, Sankila EM, Hsu Y-PP, Rinehart WB, Corey TJ, Ozelius L, Powell JF, Bruns G, Gusella JF, Murphy DL, Breakefield XO. 1989. Monoamine oxidase deficiency in males with an X chromosome deletion. Neuron 2:1069-1076.
24. Sunderland T, Mueller EA, Cohen RM, Jimerson DC, Pickar D, Murphy DL. 1985. Tyramine pressor sensitivity changes during deprenyl treatment. Psychopharmacology (Berlin) 86:432-437.
25. Tivol EA, Shalish C, Schuback DE, Breakefield XO. 1996. Mutational analysis of the human MAOA gene. Am J Med Genet (Neuropsychiatr Genet) 67:92-97.
26. Weyler W, Hsu Y-P, Breakefield XO. 1990. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 47:391-417.